Clinical trials
Observational Neuromyelitis Optica trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2012 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
| Completed | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Texas Southwestern Medical Center | 3 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Jagannadha R Avasarala | 2 |
| Mayo Clinic | 2 |
| Accelerated Cure Project for Multiple Sclerosis | 1 |
| Amgen | 1 |
| Cedars-Sinai Medical Center | 1 |
| Charles M Knudson | 1 |
| CorEvitas | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuromyelitis Optica | 15 |
| Multiple Sclerosis | 6 |
| Myelitis, Transverse | 3 |
| Optic Neuritis | 3 |
| Encephalomyelitis, Acute Disseminated | 2 |
| Multiple Sclerosis, Relapsing-Remitting | 2 |
| Atypical Hemolytic Uremic Syndrome | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Demyelinating Autoimmune Diseases, CNS | 1 |
| Hemoglobinuria, Paroxysmal | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.